Skip to main content

NRC Health

NRC
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0000070487

No open-market purchases or sales by NRC Health insiders were filed in the last 90 days; 123 institutions reported holding it in 13F filings for Q2 2026, worth $231.9M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding NRC Health changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of NRC: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders1162110−4
Shares11.5M15.2K11.5M+22.1K (+0.2%)
Value$456.3M$603.0K$441.0M−$14.7M (−3.2%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held NRC Health at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to NRC in Q2 2022
InstitutionSharesValue% of portfolio
Williams Jones Wealth Management, LLC.44,294$1.70M0.03%
Cardinal Capital Management11,138$426.0K0.10%
First Horizon Advisors, Inc.212$8.00K0.00%
Parallel Advisors, LLC110$4.00K0.00%
Manchester Capital Management LLC17$1.00K0.00%

Sold out (9)

Institutions that held NRC Health at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held NRC Health at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NRC in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC12,941$513.0K
Amalgamated Financial Corp.2,278$90.0K